CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 11 No. 5
The Logemann et al Article Reviewed 

Speech and Swallowing Rehabilitation for Head and Neck Cancer Patients

By David E. Schuller, MD, Department of Otolaryngology, Arthur G. James Cancer Hospital and Research Institute Columbus, Ohio | May 1, 1997

This paper is an excellent overview of speech and swallowing rehabilitation in head and neck cancer patients. Dr. Logemann and co-workers are clearly leaders in this field and, as such, are eminently qualified to summarize the topic. This subject is of great importance, as the effects of head and neck cancer and its treatment can be economically, psychologically, and socially devastating to patients. Quality-of-life issues continue to be critical in this patient population.

The information contained within the paper is comprehensive but somewhat oversimplified. This is because contemporary surgical technology has surpassed the ability to succinctly describe the myriad varieties of procedures in current use by head and neck surgical oncologists. The reader needs to be aware that certain terms, such as hemilaryngectomy and supraglottic laryngectomy, are now used to collectively characterize numerous procedures that are each distinctly different and can potentially have either a beneficial or an adverse impact on patients' ultimate speech and swallowing functions.

For example, the authors state that when a significant part of the tongue base is removed, the patient may never be able to relearn to swallow, requiring conversion of the surgical procedure to a total laryngectomy. In fact, recent reconstructive developments using tissue transfer techniques seem to avoid the necessity of total laryngectomy with resection of the tongue base.

The information presented by the authors on the apparent benefits of range of motion (ROM) exercises is intriguing. However, it is unclear whether patients who did and did not receive instruction in ROM exercises had similar-stage disease, underwent similar antitumor treatments, and had similar comorbid factors, or whether they were ultimately randomized to treatment groups. Although this is a simple statement to make, undertaking a controlled study in patients with head and neck cancer is a difficult task. However, there is no question that all of these factors can adversely affect the ability to effectively rehabilitate the patient.

In addition, head and neck cancer patients tend to be noncompliant,[1-3] and it is difficult to imagine sustaining adherence to an ROM exercise program in this patient population. These comments are made not as a criticism of the data presented in this article, but rather, as a statement of reality that addresses the importance of close communication among health-care professionals involved in treating this complex patient population.

The authors make the strong statement that all head and neck cancer patients "should be evaluated" following treatment. In these times of cost containment, it is critically important that all health-care professionals recognize the importance of focused utilization of consultants and technologies directed by the head and neck surgical oncologist. Once again, that is why this area requires close communication among health-care professionals to coordinate the appropriate utilization of these services.

In my opinion, it is essential that the head and neck surgical oncologist be the leader of this effort because of the surgeon's intimate knowledge of the patient's overall health status and stage of disease, but especially because of his or her knowledge of precisely what was accomplished at the time of surgery in terms of the amount of tissue resected and the reconstructive techniques utilized. The numerous modifications of standardized surgical techniques now available necessitate an interactive communication network. Hopefully, this will maximize the efficiency of other health-care professionals to optimize the results of their efforts. I have personally experienced numerous examples of the inappropriate involvement of speech and swallowing therapists by health-care professionals who were not even knowledgeable about the patient's disease or specific surgical or nonsurgical treatment he or she had received.

In summary, Dr. Logemann and her co-workers should be congratulated on an excellent paper. Head and neck cancer patients will certainly benefit from their continued research addressing critically important rehabilitation issues in this patient population.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.



Jeri A. Logemann, PhD, Barbara Roa Pauloski, PhD, Alfred W. Rademaker, PhD, and Laura A. Colangelo, MS


1. Laramore GE, Scott CB, Al-Sarraf M, et al: Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report on Intergroup study 0032. Int J Radiat Oncol Biol Phys 23:705-713, 1992.

2. Schuller DE: Do otolaryngologist-head and neck surgeons and/or chemotherapy have a role in the treatment of head and neck cancer? Arch Otolaryngol Surg 117:498-501, 1991.

3. Schuller DE, Metch B, Stein DW, et al: Preoperative chemotherapy in advanced resectable head and neck cancer: Final report of the Southwest Oncology Group. Laryngoscope 98:1205-1211, 1988.


 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
James B. Yu, MD1 , May 17, 2013

A 70-year-old man with a history of localized prostate cancer treated with whole-pelvis radiation therapy with a boost to the prostate, in conjunction with androgen deprivation therapy 7 years prior, presented with lower back pain. A bone scan revealed an area of activity in the sacrum. What is the most likely diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Colorectal Lesions
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
  • Staying Fit Could Ward Off Lung and Colorectal Cancer for Middle-Age Men
  • Obesity Impairs Efficacy of L-Asparaginase in Leukemia Treatment
  • New AUA Guidelines for Prostate Cancer Screening
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy